148 related articles for article (PubMed ID: 12366873)
21. Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.
Saletu B; Grünberger J; Rajna P
Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):369S-383S. PubMed ID: 6407499
[TBL] [Abstract][Full Text] [Related]
22. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
Saletu B; Grünberger J
Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):137-51. PubMed ID: 4010387
[TBL] [Abstract][Full Text] [Related]
23. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
[TBL] [Abstract][Full Text] [Related]
24. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
[TBL] [Abstract][Full Text] [Related]
25. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
Saletu B; Grünberger J; Rajna P; Karobath M
J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
[TBL] [Abstract][Full Text] [Related]
26. Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping.
Saletu B; Anderer P; Kinsperger K; Grünberger J; Sieghart W
Int Clin Psychopharmacol; 1988 Oct; 3(4):287-323. PubMed ID: 3235816
[TBL] [Abstract][Full Text] [Related]
27. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.
Saletu B; Grünberger J
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):45-52. PubMed ID: 3882681
[TBL] [Abstract][Full Text] [Related]
28. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
[TBL] [Abstract][Full Text] [Related]
29. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression.
Saletu B; Anderer P; Saletu-Zyhlarz GM
Clin EEG Neurosci; 2010 Oct; 41(4):203-10. PubMed ID: 21077572
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):362-73. PubMed ID: 3525428
[TBL] [Abstract][Full Text] [Related]
31. Acute nicotine administration in Alzheimer's disease: an exploratory EEG study.
Knott V; Engeland C; Mohr E; Mahoney C; Ilivitsky V
Neuropsychobiology; 2000; 41(4):210-20. PubMed ID: 10828731
[TBL] [Abstract][Full Text] [Related]
32. Effects of caffeine on topographic quantitative EEG.
Siepmann M; Kirch W
Neuropsychobiology; 2002; 45(3):161-6. PubMed ID: 11979068
[TBL] [Abstract][Full Text] [Related]
33. Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.
Saletu B; Grünberger J; Linzmayer L; Anderer P
Psychopharmacology (Berl); 1992; 109(1-2):30-40. PubMed ID: 1365669
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
[TBL] [Abstract][Full Text] [Related]
35. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
[TBL] [Abstract][Full Text] [Related]
36. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
Saletu B; Grünberger J
Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):317-30. PubMed ID: 6431211
[TBL] [Abstract][Full Text] [Related]
37. Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.
Saletu B; Möller HJ; Grünberger J; Deutsch H; Rössner M
Neuropsychobiology; 1990-1991; 24(4):173-84. PubMed ID: 2135708
[TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
Saletu B; Grünberger J; Linzmayer L; Anderer P
Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
[TBL] [Abstract][Full Text] [Related]
39. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
Herrmann WM; Schärer E; Wendt G; Delini-Stula A
Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
[TBL] [Abstract][Full Text] [Related]
40. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
Saletu B; Grünberger J; Linzmayer L; Schwartz JJ; Haegele KD; Schechter PJ
Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]